Prof. Dr. Armin Schwarzbach | 4th International Congress of Integrative Medicine
ICIM 2023...

Prof. Dr. Armin Schwarzbach



New 3 I model: Infection, inflammation and immune dysfunction

Chronic manifestations of virus infections are complex interactions between host immunity and stealth bacteria and viruses with emerging evidence for the development of different kinds of illnesses. 

Nutrition and gut immunity plays a very important role in this complexity. Virus infections are the chameleons of symptoms, diagnostic test results and therapy options. Since Covid 19 epidemic started there is more consciousness and knowledge about testings, trackings and therapy options during and after virus infections including Post Covid / Long Covid. 

There is more and more evidence about opportunistic infections and especially viral infections as for example Epstein Barr Virus, Cytomegalovirus, Coxsackie-Virus infections in Post Covid / Long Covid to cause chronic inflammation and weaken the host immune system and coagulopathies, resulting in treatment problems. Modern laboratory test options like IgA-antibodies or cellular immune tests (EliSpots and CD3/CD56/CD57 markers), examples of laboratory test reports for different opportunistic infections with viruses, clinical symptoms and differentials of viral infections in different kinds of illnesses, and conclusions about the approach how to diagnose, treat and track virus infections will be shown during the presentation including the importance of 3 I´s (infection, immune-dysfunction, inflammation).

CV Resumido

Dr. Armin Schwarzbach, MD, has worked in the field of laboratory medicine and infectious diseases for more than 30 years and in 2015 created his own laboratory in Augsburg, Germany which has developed in leaps and bounds since then. He has become a world expert in his field and has lectured around the world on his subject. Today his laboratory has 30 employees and provides medical testing services for practitioners all more than 150 countries. ArminLabs is doing around 500 samples processing every day for Lyme and coinfected patients. Over the years ArminLabs has done laboratory tests for over 150.000 Lyme and coinfected patients worldwide.

ArminLabs is accredited by German Accreditation Authorities DAkkS.

Armin studied Pharmacy and Medicine at the University of Mainz Department of Endocrinology and after completing his PhD in 1992 on “Analytical Assay for the detection of human Gastric Inhibitory Polypeptide (hGIP) by Radioimmunoassay“. He developed the first worldwide test system for human GIP he obtained his qualification to practice as a medical doctor in 1993, and then in 1997 he obtained further degree as a Specialist of Laboratory Medicine.

He gained his laboratory and medical experience working in different hospitals and laboratories in Limburg, Koblenz, Munich, Augsburg and Weisbaden up until 2006 when he joined BCA Laboratory and became its CEO, up until 2015.

Wanting to develop his own range of specialist tests to help practitioners better address the diagnosis of chronic infections, ArminLabs was created in 2015 and he has been its CEO and Managing Director until this day.

As a member of the German Society for Specialists of Laboratory Medicine, Board Member of German Society for Clinical Chemistry and Laboratory Medicine, the German Borreliosis Society, The Swiss Association for Tick-borne diseases and the Australasian Integrative Medicine Association, member and former Board member of ILADS (International Lyme and Associated Diseases Socitey) USA since 2005.

Armin is extremely well connected in this field and his extensive knowledge and managerial skills have grown ArminLabs to the powerhouse and renowned laboratory that it is today.

Armin is very much involved in, and continues to pushing forward, advances to improve testing and treatment options and regularly gives webinars, attends conferences and (increasingly in today’s world) gives video conferences on his areas of expertise. He continues to practice as a medical doctor and frequently helps practitioners to determine the best testing protocols and how to use these to diagnose patients whilst continuing to be intimately involved with the running of his laboratory